Tri-Heal Max 45mg TB-500 25mg + BPC-157 10mg + KPV 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

Tri-Heal Max is a multi-component research peptide blend composed of BPC-157, KPV and Thymosin Beta-4 (TB-500). This formulation is studied in laboratory environments for its relevance in cellular repair signalling, inflammatory pathway modelling and cytoskeletal response mechanisms. The lyophilized 45 mg preparation supports reproducible in vitro research across complex peptide-interaction and tissue-response models.

Peptide Overview

BPC-157 is a synthetic peptide fragment derived from a naturally occurring gastric protein and has been extensively investigated since the late 1990s in research models focusing on cellular integrity and tissue-response signalling. KPV is a tripeptide fragment of alpha-melanocyte-stimulating hormone, studied for its role in inflammatory signalling modulation and peptide–receptor interaction research. TB-500, a synthetic analogue of thymosin beta-4, has been examined for its involvement in actin-binding dynamics and cytoskeletal organisation.

When evaluated together, these peptides enable researchers to explore coordinated cellular communication, signalling balance and multi-pathway interaction behaviour within regenerative and repair-oriented biochemical systems.

Historical Background and Scientific Context

From the late twentieth century onward, peptide-based research expanded significantly as laboratories sought to better understand cellular repair, inflammatory signalling and cytoskeletal dynamics. Multi-peptide research blends such as BPC-157, KPV and thymosin-derived peptides have been incorporated into preclinical research frameworks to study complex biological response systems under controlled laboratory conditions.

Mechanistic Focus in Research

• Cellular repair and tissue-response signalling modelling
• Inflammatory pathway and peptide–receptor interaction studies
• Cytoskeletal organisation and actin-dynamics research
• Multi-peptide signalling synergy evaluation
• Controlled in vitro cellular response investigations

Analytical Verification (COA)

Independent Liquilabs analysis confirms full validation for Batch GF092025045. Key analytical results include:

• BPC-157 Assay Content: 12.70 mg (RT 0.994)
• KPV Assay Content: 13.19 mg (RT 0.984)
• Thymosin Beta-4 (TB-500) Assay Content: 29.7 mg (RT 0.990)
• Endotoxins: below 0.001 EU per mg
• Bioburden: not detected
• Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium

All analytical values were obtained using validated chromatographic, spectroscopic and microbiological procedures, ensuring transparent documentation and complete batch traceability.

Research Applications

• Cellular repair and tissue-response research
• Inflammatory signalling and modulation studies
• Cytoskeletal and actin-dynamics investigation
• Multi-peptide interaction and synergy evaluation
• Controlled in vitro cellular signalling models

Grail Formula Quality

Every Grail Formula research peptide blend undergoes independent third-party laboratory testing for identity, assay accuracy, purity and microbial safety. Each batch is verified for low endotoxin levels, analytical consistency and reproducibility to support reliable scientific research outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptide materials with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity multi-peptide research blend
Validated assay content BPC-157, KPV and TB-500
Retention time identification and full COA traceability
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.